Onconephrology

Maria P. Martinezcantarin, Christina Mejia

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

As cancer survival has improved over the years, more cancer patients will experience side effects of treatment and survive long enough to develop conditions like chronic kidney disease. Kidney function is considered in the choice and dosing of chemotherapeutic drugs, and development of chronic kidney disease (CKD) and acute kidney injury can complicate medication and patient management. Development of acute kidney injury (AKI) is common during the clinical course of cancer patients and can be due to cancer-nonspecific causes like volume depletion and cancer-related causes like in multiple myeloma or can be therapy-related. The pathophysiology behind therapy-related AKI has broadened with the advent of targeted and immune-mediated cancer therapy. For patients who eventually progress to end-stage renal disease (ESRD), the discussion of pursuing renal replacement therapy is complex as both cancer and ESRD have their own impact on mortality and quality of life.

Original languageEnglish (US)
Title of host publicationApproaches to Chronic Kidney Disease
Subtitle of host publicationA Guide for Primary Care Providers and Non-Nephrologists
PublisherSpringer International Publishing
Pages185-209
Number of pages25
ISBN (Electronic)9783030830823
ISBN (Print)9783030830816
DOIs
StatePublished - Jan 1 2021

Keywords

  • Acute kidney injury
  • Cancer
  • Chemotherapy
  • Chronic kidney disease
  • Immunotherapy
  • Paraproteinemia
  • Targeted therapy
  • Tumor lysis syndrome

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Onconephrology'. Together they form a unique fingerprint.

Cite this